Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2010
12/08/2010EP2257552A1 Heterocyclic compounds as inhibitors of cxcr2
12/08/2010EP2257161A1 Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia
12/08/2010EP2150548B1 Process for hcv protease inhibitor intermediate
12/08/2010EP1781290B1 Anti-inflammatory agents
12/08/2010EP1578351B1 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
12/08/2010CN1930168B 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and compositions containing said compounds
12/08/2010CN1759118B Diazepinoindole derivatives as kinase inhibitors
12/08/2010CN1696162B Process for producing contact product, catalyst component for addition polymerization, process for producing catalyst for addition polymerization, and process for producing addition polymer
12/08/2010CN101910178A Gamma secretase modulators
12/08/2010CN101910177A Macrocyclic indoles as hepatitis c virus inhibitors
12/08/2010CN101910151A Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119
12/08/2010CN101910133A Heterocycle phenyl amide T-type calcium channel antagonists
12/08/2010CN101906106A Novel heterocyclic compounds as HSP90-inhibitors
12/08/2010CN101906105A Pyrazolo (1,5-a) pyrimidone derivative as well as drug combination thereof and application thereof
12/08/2010CN101302219B Fluorene derivative containing large conjugated molecule and preparation thereof
12/08/2010CN101142217B Imidazopyridazine compounds
12/08/2010CN101039946B Disubstituted pyrazolobenzodiazepines useful as inhibitors for CDK2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
12/08/2010CN101035791B Pyrrolo[1,2-D][1,2-4]triazine as inhibitors of c-JUN N terminal kinases (JNK) and P-38 kinases
12/07/2010US7846944 P38 map kinase inhibitors such as N-cyclopropyl-3-(7-ethyl-1-(2-fluorophenyl)-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-5-yl)-5-fluoro-4-methylbenzamide, used for the treatment of rheumatoid arthritis, psoriasis, chronic obstructive pulmonary disease, pain and other inflammatory disorders
12/07/2010US7846931 Pyrrolotriazine compounds as kinase inhibitors
12/07/2010US7846559 Heterocyclic compound and an organic light emitting device comprising the same
12/07/2010CA2468542C Synthesis of 2-cyanoaziridine-1-carboxamide
12/02/2010WO2010138833A1 SUBSTITUTED IMIDAZO[1,5-a]QUINOXALINES AS INHIBITORS OF PHOSPHODIESTERASE 10
12/02/2010WO2010138633A1 Method of providing neuroprotection using substituted porphyrins
12/02/2010WO2010138589A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010WO2010138576A1 Pyrimidine inhibitors of kinase activity
12/02/2010WO2010138575A1 Pyrimidine inhibitors of kinase activity
12/02/2010WO2010138490A1 Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
12/02/2010WO2010138487A1 BENZOXAZEPINES AS INHIBITORS OF PI3K/m TOR AND METHODS OF THEIR USE AND MANUFACTURE
12/02/2010WO2010136491A1 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010WO2010136109A1 Materials for organic electroluminescent devices
12/02/2010WO2010117738A3 Solid state forms of sitagliptin salts
12/02/2010US20100305319 Method of purifying a salt, sodium salt and disodium salt of pemetrexed
12/02/2010US20100305318 Process for the Manufacture of Anagrelide Hydrochloride Monohydrate
12/02/2010US20100305315 Process for the preparation of 2-(primary/secondary amino)hydrocarbyl)-carbamoyl-7-oxo-2,6-diaza-bicyclo [3.2.0.]heptane-6-sulfonic acid derivatives
12/02/2010US20100305314 Geometric synthesis of porphyrin rods
12/02/2010US20100305149 Polyal Drug Conjugates Comprising Variable Rate-Releasing Linkers
12/02/2010US20100305143 Pyrrolopyrimidine compounds
12/02/2010US20100305137 Piperazine derivatives and methods of use
12/02/2010US20100305135 Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010US20100305113 Substituted Imidazopyridazines as Lipid Kinase Inhibitors
12/02/2010US20100305107 Quinoline derivatives and their use as 5-ht6 ligands
12/02/2010US20100305091 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES
12/02/2010US20100305083 Substituted porphyrins
12/02/2010US20100305070 Treatment or prophylaxis of proliferative conditions
12/02/2010US20100303728 Caspase imaging probes
12/02/2010CA2772371A1 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010CA2763631A1 Pyrimidine inhibitors of kinase activity
12/02/2010CA2763624A1 Pyrimidine inhibitors of kinase activity
12/02/2010CA2763008A1 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
12/02/2010CA2762474A1 Method of providing neuroprotection using substituted porphyrins
12/02/2010CA2761445A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/01/2010EP2256842A1 Organic electroluminescent device
12/01/2010EP2256119A1 Vasopressin V1a antagonists
12/01/2010EP2256118A1 Condensed imidazolo derivatives for the inhibition of aromatase
12/01/2010EP2256103A1 Novel indicator platform
12/01/2010EP2255803A1 Oral galenic formulation including ketorolac and b-complex vitamins, in which vitamin b6 is in an outer layer separated from the rest of the active principles
12/01/2010EP2255801A1 Pharmaceutically active isoindoline derivatives
12/01/2010EP2254413A1 Imidazobenzazepine cgrp receptor antagonists
12/01/2010EP1945645B1 Crystalline forms of pemetrexed diacid and processes for the preparation thereof
12/01/2010EP1651649B1 Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medication
12/01/2010CN101903392A Inhibitors of serine proteases
12/01/2010CN101903391A Process for the preparation of a macrocycle
12/01/2010CN101903390A Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
12/01/2010CN101903387A 8-anilin0imidaz0pyridines and their use as anti-cancer and/or anti-inflammatory agents
12/01/2010CN101903382A Heterocyclic antiviral compounds
12/01/2010CN101903027A Preventive or therapeutic agent for inflammatory bowel disease
12/01/2010CN101901875A Carbazole derivative and organic light-emitting device using same
12/01/2010CN101899050A Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
12/01/2010CN101899049A Disubstituted pyrazolobenzodiazepines
12/01/2010CN101899048A Salt of (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1- carboxylic acid methyl ester
12/01/2010CN101899047A Beta-amino tetrahydropyrazine, tetrahydropyrimidine and tetrahydropyridine used as dipeptidy peptidase inhibitors for curing or preventing diabetes
12/01/2010CN101899046A Method for synthesizing persantine intermediate 2,4,6,8-tetrahydroxy pyrimido[5,4-d] pyrimidine
12/01/2010CN101133056B Anti-tumor compounds
11/2010
11/30/2010US7842814 deprotecting, aldol condensations, cleaving double bonds, deesterifying, alcoholization, oxidation with organometallic, lactonization
11/30/2010US7842808 Anti-migraine spirocycles
11/30/2010US7842802 Vinorelbine derivatives
11/30/2010US7842801 using a photosensitizer,containing phthalocyanine ring with pendant phenylsulfonate moieties linked through a secondary amide and complexed with a copper, zinc, nickel, manganese, cobalt, aluminum or vanadium central metal; and a carrier to detect cancer for photodynamic therapy
11/30/2010US7842699 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases
11/30/2010US7842687 Cephalotaxane derivatives and their processes of preparation and purification
11/30/2010US7842682 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof
11/30/2010CA2497444C Pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/30/2010CA2144474C Substituted n-ethylglycine derivatives for preparing pna and pna/dna hybrids
11/25/2010WO2010135650A1 N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
11/25/2010WO2010135621A1 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
11/25/2010WO2010135560A1 Modulators of 5-ht receptors and methods of use thereof
11/25/2010WO2010135524A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
11/25/2010WO2010133836A1 Fused bicyclic pyrazole derivatives as kinase inhibitors
11/25/2010WO2010132953A1 Heptaazaphenalene derivatives and use thereof in organic electroluminescent device
11/25/2010WO2010112452A9 Oligocondensed perylene bisimides
11/25/2010WO2010088050A3 Bicyclic pyrazolo-heterocycles
11/25/2010WO2010085820A3 Tricyclic compounds as antagonists of prostaglandin d2 receptors
11/25/2010WO2010027448A8 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists
11/25/2010WO2009142842A9 Novel macrocyclic inhibitors of hepatitis c virus replication
11/25/2010US20100298563 PYRAZOLOPYRIMIDINE DERIVATIVES HAVING BIOLOGICAL ACTIVITY ON SEROTONIN RECEPTOR 5-HT2c
11/25/2010US20100298557 Pyrazolopyrimidine compound
11/25/2010US20100298378 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
11/25/2010US20100298355 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
11/25/2010US20100298351 Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti-cancer agents
1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 573